Wells Fargo notes that the Federal Circuit court ordered the Patent Trial and Appeal Board, or PTAB, to reconsider two IPR petitions that had been brought by Axonics (AXNX) against patents held by Medtronic (MDT). The firm, which says its patent consultant views this as a positive update for Axonics and thinks the company’s position is “meaningfully improved,” has an Overweight rating on Axonics shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AXNX: